These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18330834)

  • 1. Drug-induced psoriasis: results from pharmacovigilance tools under investigation.
    Hauben M; Reich L; Magliano S; Song A
    Cutan Ocul Toxicol; 2008; 27(1):55-9. PubMed ID: 18330834
    [No Abstract]   [Full Text] [Related]  

  • 2. Data mining for signals in spontaneous reporting databases: proceed with caution.
    Stephenson WP; Hauben M
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric pharmacovigilance.
    Prescrire Int; 2002 Dec; 11(62):183. PubMed ID: 12472099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Criteria of imputability in accidents of drug-induced origin].
    Bégaud B
    Rev Prat; 2000 Oct; 50(16):1803-6. PubMed ID: 11103134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of reports on "pregnancy and drugs" received during a period of 39 months by the Regional Pharmacovigilance Center, Lorraine (Nancy)].
    Hanesse B; Trechot P; el Kouch S; Pierfitte C; Royer R; Netter P
    Therapie; 1995; 50(5):471-2. PubMed ID: 8571291
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reactions in a department of pediatric surgery.
    Farrokhi S; Nahvi H; Pourpak Z; Moin M; Majdinasab P; Gholami K; Kazemnejad A
    J Trop Pediatr; 2006 Feb; 52(1):72-3. PubMed ID: 15980025
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative signal detection using spontaneous ADR reporting.
    Bate A; Evans SJ
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacovigilance].
    Livio F; Renard D; Buclin T
    Rev Med Suisse; 2012 Jan; 8(324):116-9. PubMed ID: 23185821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reaction reporting--2000: Part 1.
    Sutcliffe H
    CMAJ; 2001 Apr; 164(7):1038, 1042. PubMed ID: 11314437
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events.
    Bukirwa H; Nayiga S; Lubanga R; Mwebaza N; Chandler C; Hopkins H; Talisuna AO; Staedke SG
    Trop Med Int Health; 2008 Sep; 13(9):1143-52. PubMed ID: 18631312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EU pharmacovigilance guidelines. Review.
    Fletcher AP
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):123-6. PubMed ID: 10967747
    [No Abstract]   [Full Text] [Related]  

  • 13. Baclofen-induced psoriasis.
    Sigg N; Delaunay J; Potey C; Drablier G
    Ann Dermatol Venereol; 2022 Dec; 149(4):291-293. PubMed ID: 35643883
    [No Abstract]   [Full Text] [Related]  

  • 14. Data mining in pharmacovigilance: lessons from phantom ships.
    Hauben M; Reich L; Van Puijenbroek EP; Gerrits CM; Patadia VK
    Eur J Clin Pharmacol; 2006 Nov; 62(11):967-70. PubMed ID: 16896782
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent news about drug risks: application to Canadians.
    Hogan V; Turner C
    CMAJ; 1998 Oct; 159(7):845-6; 849-50. PubMed ID: 9805036
    [No Abstract]   [Full Text] [Related]  

  • 16. Studying the causes of adverse drug reactions: circumvent the warning-interfered bias using the case-case comparison approach.
    Wang LY; Lee WC
    J Clin Epidemiol; 2008 May; 61(5):516. PubMed ID: 18394547
    [No Abstract]   [Full Text] [Related]  

  • 17. A computerized system for signal detection in spontaneous reporting system of Shanghai China.
    Ye X; Fu Z; Wang H; Du W; Wang R; Sun Y; Gao Q; He J
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):154-8. PubMed ID: 19115240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study finds problems with reporting side effects.
    TreatmentUpdate; 2002 Jul; 14(5):3-4. PubMed ID: 12141280
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project.
    Bousquet PJ; Demoly P; Romano A; Aberer W; Bircher A; Blanca M; Brockow K; Pichler W; Torres MJ; Terreehorst I; Arnoux B; Atanaskovic-Markovic M; Barbaud A; Bijl A; Bonadonna P; Burney PG; Caimmi S; Canonica GW; Cernadas J; Dahlen B; Daures JP; Fernandez J; Gomes E; Gueant JL; Kowalski ML; Kvedariene V; Mertes PM; Martins P; Nizankowska-Mogilnicka E; Papadopoulos N; Ponvert C; Pirmohamed M; Ring J; Salapatas M; Sanz ML; Szczeklik A; Van Ganse E; De Weck AL; Zuberbier T; Merk HF; Sachs B; Sidoroff A;
    Allergy; 2009 Feb; 64(2):194-203. PubMed ID: 19178398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
    Ahmed I; Haramburu F; Fourrier-Réglat A; Thiessard F; Kreft-Jais C; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
    Stat Med; 2009 Jun; 28(13):1774-92. PubMed ID: 19360795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.